← Leaderboards
Edward J Kim
University Of California At Davis
$988,864
Attributed
$2,355,574
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $922.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,355,574 · 2
By mechanism
R01$1,822,280 · 1
P30$533,294 · 1
Top collaborators
- Mansoor M. Amiji5 shared
- James E Egan5 shared
- Gerardo Guillermo Mackenzie5 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Xiao-Jing Wang$25,575,023
- Charles Decarli$84,485,572
- Kit S Lam$32,497,491
- Laura Marcu$16,612,855
- Mansoor M. Amiji$9,305,730
Others in their field
Other Rising Stars on “Research Personnel”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,758,787
- Mari Ostendorf · University Of Washington$51,931,230
- Jessica Ellis · Technical Resources International, Inc.$45,038,640
- Jeffrey Leintz · National Opinion Research Center$39,962,545
Research focus
Research PersonnelMalignant NeoplasmsCaliforniaUniversitiesCollaborationsDedicationsToxic EffectSafetyClinical TrialsClinical ResearchClinical TreatmentAnti-Pd-L1 TherapyCanis FamiliarisAffectAdvanced Pancreatic CancerCancer ImmunotherapyAnti-Pd-L1AcidsAnti-Cancer TherapeuticAntibody Therapy3-DimensionalClinically RelevantClinical TranslationCheckpoint Inhibition
Grant awards (7)
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer$572,502
R01 · FY2025 · CA
Clinical Protocol and Data Management$190,717
P30 · FY2025 · CA · contact PI
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer$86,583
R01 · FY2025 · CA
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer$496,381
R01 · FY2024 · CA
Clinical Protocol and Data Management$342,577
P30 · FY2024 · CA · contact PI
TGX-1214 - Combination strategy for the treatment of advanced pancreatic cancer$83,743
R01 · FY2024 · CA
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer$583,071
R01 · FY2023 · CA